Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats.

MLA

Abdel-Fattah, Maha M., et al. “Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats.” Pharmaceuticals (14248247), vol. 16, no. 4, Apr. 2023, p. 533. EBSCOhost, https://doi.org/10.3390/ph16040533.

APA

Abdel-Fattah, M. M., Hassanein, E. H. M., Sayed, A. M., Alsufyani, S. E., El-Sheikh, A. A. K., Arab, H. H., & Mohamed, W. R. (2023). Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats. Pharmaceuticals (14248247), 16(4), 533. https://doi.org/10.3390/ph16040533

Chicago

Abdel-Fattah, Maha M., Emad H. M. Hassanein, Ahmed M. Sayed, Shuruq E. Alsufyani, Azza A. K. El-Sheikh, Hany H. Arab, and Wafaa R. Mohamed. 2023. “Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats.” Pharmaceuticals (14248247) 16 (4): 533. doi:10.3390/ph16040533.